ARCHIVES

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Search Committee Finishes Job, Submits Choices To Califano

April 15, 1977

AACR Says 5 Percent Of Meeting Registrants Couldn’t Attend Due To Volcanic Ash In Europe

April 30, 2010

FDA Accepts Advisory Committee’s Recommendations On NDA, Labeling

October 26, 1979

NCI Advisory Board Approves Three Concepts

December 19, 2014

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

February 25, 2011